Menu Close Menu

Fewer cancers.
Better survival.
Equity for all.

Systemic Anti-Cancer Therapy Regimen Library

New Zealand Medicine Formulary Terms and Conditions and Disclaimer

Terms and Conditions

Download Terms and Conditions.

Disclaimer

While every care has been taken in compiling the NZF, to the extent permitted by law, the New Zealand Medicines Formulary Limited Partnership, the originators of the information provided through the NZF, and their respective officers, agents and employees, take no responsibility for any errors, omissions or inaccuracies, give no representation or warranty as to the specification’s accuracy, completeness, or suitability for any particular purpose and shall not be liable for any losses, costs, damages (incurred directly or indirectly) or other consequences whatsoever arising there from.

The NZF is not intended to provide information on the market status of all medicines available in New Zealand.

Any medicines that have not been approved for use in New Zealand in accordance with the Medicines Act 1981, or any unauthorised use of medicines that have been approved, and are listed on the NZF, may only be supplied or used (as the case may be) in accordance with clauses 25 and 29 of that Act. New Zealand Medicines Formulary Limited Partnership, and its officers, agents and employees, makes no representation or warranty as to whether any medicine, or its use as described on the NZF, is approved in accordance with the Medicines Act 1981.

New Zealand Medicines Formulary Limited Partnership, and its officers, agents and employees, assume no responsibility for action or inaction by any other party based on the information found in this publication and readers are urged to seek appropriate professional advice before taking any steps in reliance on this information.

The information in this publication is specifically designed to address conditions and requirements in New Zealand and support health professionals in New Zealand familiar with the scope and organisation of information within the NZF and as such assumes the level of professional training required to appropriately interpret the advice contained therein. The information should be interpreted in light of professional knowledge and supplemented as necessary by specialised publications and by reference to product literature.


 

Cancer Type